SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 6.6% Passive Stake in Bicara Therapeutics Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a 6.6% beneficial ownership stake in Bicara Therapeutics Inc. as of March 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson jointly filed an Amendment No. 1 to Schedule 13G, updating their beneficial ownership in Bicara Therapeutics Inc.
- As of March 31, 2025, the reporting persons collectively beneficially own 3,611,573 shares of Bicara Therapeutics Inc. Common Stock.
- This aggregate ownership represents 6.6% of the total outstanding common stock of Bicara Therapeutics Inc.
- FMR LLC holds sole voting power over 3,610,687 shares and sole dispositive power over 3,611,573 shares.
- Abigail P. Johnson holds sole dispositive power over 3,611,573 shares.
- The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
- The filing includes a Rule 13d-1(k)(1) agreement, indicating a joint filing by the undersigned persons.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or prospects.
Future Outlook
The document is a beneficial ownership disclosure and does not contain any forward-looking statements or guidance regarding the issuer's future outlook.
Industry Context
This filing pertains to a significant beneficial ownership stake held by FMR LLC, a major global asset management firm, and its affiliates. Such filings are standard disclosures for large institutional investors exceeding a 5% ownership threshold in publicly traded companies, reflecting their investment positions rather than operational details of the issuer.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor's stake can influence market perception and potentially provide a signal of confidence or concern, depending on the context of the filing (e.g., new stake vs. reduction).
Key Dates
| Date | Description |
|---|---|
| January 3, 2023 | Effective date of Power of Attorney for FMR LLC. |
| January 26, 2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| March 31, 2025 | Date of event which requires filing of this statement. |
| May 9, 2025 | Date of filing and Rule 13d-1(k)(1) agreement. |
Keywords
BICARA THERAPEUTICS INC, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.